shineyee的个人主页 - 老虎社区

shineyee

暂无个人介绍

IP属地：未知

4关注

1粉丝

0主题

0勋章

2021-11-09

Yup

General Electric shares jumped more than 8% in premarket trading.<blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote>

2021-11-09

Ok

抱歉，原内容已删除

2021-11-09

Ok

抱歉，原内容已删除

2021-11-09

Like

Nasdaq 100’s Sizzling Run to Record Flashes Warning<blockquote>纳斯达克100的火热运行记录闪光警告</blockquote>

2021-11-09

Like

Magic Mushroom-Based Therapy for Depression Shows Promise<blockquote>基于神奇蘑菇的抑郁症疗法显示出希望</blockquote>

2021-11-09

Like

抱歉，原内容已删除

2021-11-05

Cool

Real Good Food Prices IPO At $12/Share, Below Expected Range<blockquote>Real Good Food IPO价格为12美元/股，低于预期范围</blockquote>

2021-11-05

Ok

抱歉，原内容已删除

2021-11-05

[财迷]

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4099194502735390","uuid":"4099194502735390","gmtCreate":1636092373396,"gmtModify":1636092373396,"name":"shineyee","pinyin":"shineyee","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":4,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.24","exceedPercentage":"60.96%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":844778274,"gmtCreate":1636464967934,"gmtModify":1636466228111,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099194502735390","authorIdStr":"4099194502735390"},"themes":[],"htmlText":"Yup","listText":"Yup","text":"Yup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844778274","repostId":"1118064093","repostType":4,"repost":{"id":"1118064093","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636457742,"share":"https://www.laohu8.com/m/news/1118064093?lang=zh_CN&edition=full","pubTime":"2021-11-09 19:35","market":"us","language":"en","title":"General Electric shares jumped more than 8% in premarket trading.<blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1118064093","media":"Tiger Newspress","summary":"General Electric shares jumped more than 8% in premarket trading.\nGE today announced its plan to for","content":"<p>General&nbsp;Electric&nbsp;shares&nbsp;jumped&nbsp;more&nbsp;than&nbsp;8%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/1049bfebf2182acd1079e4e631f5655b\" tg-width=\"882\" tg-height=\"578\" referrerpolicy=\"no-referrer\"></p><p><blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote></p><p> GE&nbsp;today announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy, by:</p><p><blockquote>GE今天宣布计划通过以下方式组建三家行业领先的全球上市公司，专注于航空、医疗保健和能源等增长领域：</blockquote></p><p> <ol>  <li>Pursuing a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023, in which GE expects to retain a stake of 19.9 percent; and</li>  <li>Combining GE Renewable Energy, GE Power, and GE Digital into one business, positioned to lead the energy transition, and then pursuing a tax-free spin-off of this business in early 2024.</li>  <li>Following these transactions, GE will be an aviation-focused company shaping the future of flight.</li> </ol></p><p><blockquote><ol><li>寻求免税分拆GE Healthcare，于2023年初在precision health中心创建一家纯粹的公司，GE预计将保留19.9%的股份；和</li><li>将GE可再生能源、GE电力和GE数字合并为一项业务，定位于引领能源转型，然后在2024年初寻求该业务的免税分拆。</li><li>完成这些交易后，通用电气将成为一家专注于航空的公司，塑造航空业的未来。</li></ol></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>General Electric shares jumped more than 8% in premarket trading.<blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGeneral Electric shares jumped more than 8% in premarket trading.<blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-09 19:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>General&nbsp;Electric&nbsp;shares&nbsp;jumped&nbsp;more&nbsp;than&nbsp;8%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/1049bfebf2182acd1079e4e631f5655b\" tg-width=\"882\" tg-height=\"578\" referrerpolicy=\"no-referrer\"></p><p><blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote></p><p> GE&nbsp;today announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy, by:</p><p><blockquote>GE今天宣布计划通过以下方式组建三家行业领先的全球上市公司，专注于航空、医疗保健和能源等增长领域：</blockquote></p><p> <ol>  <li>Pursuing a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023, in which GE expects to retain a stake of 19.9 percent; and</li>  <li>Combining GE Renewable Energy, GE Power, and GE Digital into one business, positioned to lead the energy transition, and then pursuing a tax-free spin-off of this business in early 2024.</li>  <li>Following these transactions, GE will be an aviation-focused company shaping the future of flight.</li> </ol></p><p><blockquote><ol><li>寻求免税分拆GE Healthcare，于2023年初在precision health中心创建一家纯粹的公司，GE预计将保留19.9%的股份；和</li><li>将GE可再生能源、GE电力和GE数字合并为一项业务，定位于引领能源转型，然后在2024年初寻求该业务的免税分拆。</li><li>完成这些交易后，通用电气将成为一家专注于航空的公司，塑造航空业的未来。</li></ol></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GE":"GE航空航天"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118064093","content_text":"General Electric shares jumped more than 8% in premarket trading.\nGE today announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy, by:\n\nPursuing a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023, in which GE expects to retain a stake of 19.9 percent; and\nCombining GE Renewable Energy, GE Power, and GE Digital into one business, positioned to lead the energy transition, and then pursuing a tax-free spin-off of this business in early 2024.\nFollowing these transactions, GE will be an aviation-focused company shaping the future of flight.","news_type":1,"symbols_score_info":{"GE":0.9}},"isVote":1,"tweetType":1,"viewCount":3197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844778160,"gmtCreate":1636464944962,"gmtModify":1636465147770,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099194502735390","authorIdStr":"4099194502735390"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844778160","repostId":"2182270499","repostType":4,"isVote":1,"tweetType":1,"viewCount":3442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844778951,"gmtCreate":1636464922462,"gmtModify":1636465092493,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099194502735390","authorIdStr":"4099194502735390"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844778951","repostId":"2182023117","repostType":4,"isVote":1,"tweetType":1,"viewCount":1534,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844771772,"gmtCreate":1636464911695,"gmtModify":1636465037593,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099194502735390","authorIdStr":"4099194502735390"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844771772","repostId":"1170173504","repostType":4,"repost":{"id":"1170173504","kind":"news","pubTimestamp":1636459306,"share":"https://www.laohu8.com/m/news/1170173504?lang=zh_CN&edition=full","pubTime":"2021-11-09 20:01","market":"us","language":"en","title":"Nasdaq 100’s Sizzling Run to Record Flashes Warning<blockquote>纳斯达克100的火热运行记录闪光警告</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1170173504","media":"Bloomberg","summary":"(Bloomberg) -- The tech-heavy Nasdaq 100 Index is showing serious signs of overheating, an indicatio","content":"<p>(Bloomberg) -- The tech-heavy Nasdaq 100 Index is showing serious signs of overheating, an indication that a selloff might be right around the corner.</p><p><blockquote>（彭博社）--以科技股为主的纳斯达克100指数显示出严重的过热迹象，这表明抛售可能即将来临。</blockquote></p><p> After surging 10% in the past month, the benchmark -- home of the likes of Apple Inc., Amazon.com Inc. and Microsoft Corp. -- has seen its relative strength indicator, a 0-100 gauge of bullish and bearish price momentum, soar to 78, well into overbought territory. That’s seen by traders as a contrarian signal that a decline is imminent, because buying has gotten excessive. Four of the last five times the indicator hit such a level, the Nasdaq 100 shed 12% or more to the ensuing low.</p><p><blockquote>在过去一个月飙升10%后，该基准——苹果公司、亚马逊公司和微软公司等公司的所在地——已经看到了其相对强弱指标，即看涨和看跌价格的0-100指标势头，飙升至78，已进入超买区域。交易员认为这是一个反向信号，表明下跌即将到来，因为买盘已经过度。在该指标触及这一水平的过去五次中，有四次纳斯达克100指数下跌12%或更多，跌至随后的低点。</blockquote></p><p> The latest leg of the rally has been fueled by a string of solid earnings from technology companies and the Federal Reserve’s dovish messaging on rate hikes, helping the index beat the S&amp;P 500 by more than three percentage points since the reporting season began in mid-October. But the outperformance can’t go on forever.</p><p><blockquote>科技公司一系列稳健的盈利以及美联储关于加息的鸽派信息推动了最新一轮的上涨，帮助该指数自10月中旬财报季开始以来跑赢标普500三个百分点以上。但优异的表现不可能永远持续下去。</blockquote></p><p> “It would be better if this index took a breather,” said Matt Maley, chief market strategist at Miller Tabak &amp; Co. “It would actually help the tech sector rally further into the end of the year.”</p><p><blockquote>Miller Tabak&amp;Co.首席市场策略师Matt Maley表示：“如果该指数喘口气会更好。”“这实际上将有助于科技行业在年底进一步反弹。”</blockquote></p><p> In an early sign that the Nasdaq 100 may be running out of steam, the index fell Monday for the first time in 11 sessions, snapping the longest winning streak since December 2020. It had finished last week at a record high.</p><p><blockquote>纳斯达克100指数可能正在失去动力的早期迹象是，该指数周一11个交易日来首次下跌，结束了自2020年12月以来最长的连涨势头。上周收盘创下历史新高。</blockquote></p><p> However, it’s not a given that the benchmark is headed for a double-digit decline, because it can stay at overbought levels for a long period, as in early 2020.</p><p><blockquote>然而，该基准指数并不一定会出现两位数的下跌，因为它可能会长期保持在超买水平，就像2020年初一样。</blockquote></p><p> What’s more, Citigroup Inc. strategists say the positioning on Nasdaq future contracts appeared more balanced after a chunk of bearish calls were unwound last week. “However, pockets of risk remain,” strategists led by Chris Montagu wrote in a note.</p><p><blockquote>此外，花旗集团策略师表示，在上周大部分看跌评级平仓后，纳斯达克期货合约的头寸似乎更加平衡。克里斯·蒙塔古(Chris Montagu)领导的策略师在一份报告中写道：“然而，仍存在一些风险。”</blockquote></p><p> There’s plenty of news that can help turn sentiment against the tech sector broadly: China’s regulatory crackdown is ongoing, and there are growing signs that companies that benefited from pandemic lockdowns now are suffering as economies reopen.</p><p><blockquote>有很多消息可以帮助扭转对科技行业的普遍情绪：中国的监管打压正在进行，越来越多的迹象表明，随着经济重新开放，从大流行封锁中受益的公司现在正在遭受损失。</blockquote></p><p> Monday’s rally in Chinese after-school tutoring stocks, spurred by a report that Beijing will issue new licenses, didn’t last long, signaling that investors expect China’s regulatory efforts have further to run.</p><p><blockquote>周一，在北京将发放新许可证的报道的刺激下，中国课后辅导股的上涨并没有持续多久，这表明投资者预计中国的监管努力将进一步推进。</blockquote></p><p> PayPal Holdings Inc.’s weak 2022 outlook added to concerns about slowing e-commerce sales, pushing its shares 3.8% lower in premarket trading. Among other pandemic winners, home workout equipment maker Peloton Interactive Inc. is the worst performer in the Nasdaq 100 this year with a drop of 66% and Zoom Video Communications Inc. is down 23%.</p><p><blockquote>PayPal控股公司2022年前景疲软加剧了人们对电子商务销售放缓的担忧，导致其股价在盘前交易中下跌3.8%。在其他大流行赢家中，家庭健身设备制造商Peloton Interactive Inc.是今年纳斯达克100指数中表现最差的公司，下跌了66%，Zoom Video通信公司下跌了23%。</blockquote></p><p> Meanwhile, e-commerce behemoth Amazon has risen just 7% in 2021, underperforming the Nasdaq 100’s 27% surge.</p><p><blockquote>与此同时，电子商务巨头亚马逊在2021年仅上涨了7%，表现落后于纳斯达克100指数27%的涨幅。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq 100’s Sizzling Run to Record Flashes Warning<blockquote>纳斯达克100的火热运行记录闪光警告</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq 100’s Sizzling Run to Record Flashes Warning<blockquote>纳斯达克100的火热运行记录闪光警告</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-11-09 20:01</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- The tech-heavy Nasdaq 100 Index is showing serious signs of overheating, an indication that a selloff might be right around the corner.</p><p><blockquote>（彭博社）--以科技股为主的纳斯达克100指数显示出严重的过热迹象，这表明抛售可能即将来临。</blockquote></p><p> After surging 10% in the past month, the benchmark -- home of the likes of Apple Inc., Amazon.com Inc. and Microsoft Corp. -- has seen its relative strength indicator, a 0-100 gauge of bullish and bearish price momentum, soar to 78, well into overbought territory. That’s seen by traders as a contrarian signal that a decline is imminent, because buying has gotten excessive. Four of the last five times the indicator hit such a level, the Nasdaq 100 shed 12% or more to the ensuing low.</p><p><blockquote>在过去一个月飙升10%后，该基准——苹果公司、亚马逊公司和微软公司等公司的所在地——已经看到了其相对强弱指标，即看涨和看跌价格的0-100指标势头，飙升至78，已进入超买区域。交易员认为这是一个反向信号，表明下跌即将到来，因为买盘已经过度。在该指标触及这一水平的过去五次中，有四次纳斯达克100指数下跌12%或更多，跌至随后的低点。</blockquote></p><p> The latest leg of the rally has been fueled by a string of solid earnings from technology companies and the Federal Reserve’s dovish messaging on rate hikes, helping the index beat the S&amp;P 500 by more than three percentage points since the reporting season began in mid-October. But the outperformance can’t go on forever.</p><p><blockquote>科技公司一系列稳健的盈利以及美联储关于加息的鸽派信息推动了最新一轮的上涨，帮助该指数自10月中旬财报季开始以来跑赢标普500三个百分点以上。但优异的表现不可能永远持续下去。</blockquote></p><p> “It would be better if this index took a breather,” said Matt Maley, chief market strategist at Miller Tabak &amp; Co. “It would actually help the tech sector rally further into the end of the year.”</p><p><blockquote>Miller Tabak&amp;Co.首席市场策略师Matt Maley表示：“如果该指数喘口气会更好。”“这实际上将有助于科技行业在年底进一步反弹。”</blockquote></p><p> In an early sign that the Nasdaq 100 may be running out of steam, the index fell Monday for the first time in 11 sessions, snapping the longest winning streak since December 2020. It had finished last week at a record high.</p><p><blockquote>纳斯达克100指数可能正在失去动力的早期迹象是，该指数周一11个交易日来首次下跌，结束了自2020年12月以来最长的连涨势头。上周收盘创下历史新高。</blockquote></p><p> However, it’s not a given that the benchmark is headed for a double-digit decline, because it can stay at overbought levels for a long period, as in early 2020.</p><p><blockquote>然而，该基准指数并不一定会出现两位数的下跌，因为它可能会长期保持在超买水平，就像2020年初一样。</blockquote></p><p> What’s more, Citigroup Inc. strategists say the positioning on Nasdaq future contracts appeared more balanced after a chunk of bearish calls were unwound last week. “However, pockets of risk remain,” strategists led by Chris Montagu wrote in a note.</p><p><blockquote>此外，花旗集团策略师表示，在上周大部分看跌评级平仓后，纳斯达克期货合约的头寸似乎更加平衡。克里斯·蒙塔古(Chris Montagu)领导的策略师在一份报告中写道：“然而，仍存在一些风险。”</blockquote></p><p> There’s plenty of news that can help turn sentiment against the tech sector broadly: China’s regulatory crackdown is ongoing, and there are growing signs that companies that benefited from pandemic lockdowns now are suffering as economies reopen.</p><p><blockquote>有很多消息可以帮助扭转对科技行业的普遍情绪：中国的监管打压正在进行，越来越多的迹象表明，随着经济重新开放，从大流行封锁中受益的公司现在正在遭受损失。</blockquote></p><p> Monday’s rally in Chinese after-school tutoring stocks, spurred by a report that Beijing will issue new licenses, didn’t last long, signaling that investors expect China’s regulatory efforts have further to run.</p><p><blockquote>周一，在北京将发放新许可证的报道的刺激下，中国课后辅导股的上涨并没有持续多久，这表明投资者预计中国的监管努力将进一步推进。</blockquote></p><p> PayPal Holdings Inc.’s weak 2022 outlook added to concerns about slowing e-commerce sales, pushing its shares 3.8% lower in premarket trading. Among other pandemic winners, home workout equipment maker Peloton Interactive Inc. is the worst performer in the Nasdaq 100 this year with a drop of 66% and Zoom Video Communications Inc. is down 23%.</p><p><blockquote>PayPal控股公司2022年前景疲软加剧了人们对电子商务销售放缓的担忧，导致其股价在盘前交易中下跌3.8%。在其他大流行赢家中，家庭健身设备制造商Peloton Interactive Inc.是今年纳斯达克100指数中表现最差的公司，下跌了66%，Zoom Video通信公司下跌了23%。</blockquote></p><p> Meanwhile, e-commerce behemoth Amazon has risen just 7% in 2021, underperforming the Nasdaq 100’s 27% surge.</p><p><blockquote>与此同时，电子商务巨头亚马逊在2021年仅上涨了7%，表现落后于纳斯达克100指数27%的涨幅。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/nasdaq-100-sizzling-run-record-111636464.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/nasdaq-100-sizzling-run-record-111636464.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170173504","content_text":"(Bloomberg) -- The tech-heavy Nasdaq 100 Index is showing serious signs of overheating, an indication that a selloff might be right around the corner.\nAfter surging 10% in the past month, the benchmark -- home of the likes of Apple Inc., Amazon.com Inc. and Microsoft Corp. -- has seen its relative strength indicator, a 0-100 gauge of bullish and bearish price momentum, soar to 78, well into overbought territory. That’s seen by traders as a contrarian signal that a decline is imminent, because buying has gotten excessive. Four of the last five times the indicator hit such a level, the Nasdaq 100 shed 12% or more to the ensuing low.\nThe latest leg of the rally has been fueled by a string of solid earnings from technology companies and the Federal Reserve’s dovish messaging on rate hikes, helping the index beat the S&P 500 by more than three percentage points since the reporting season began in mid-October. But the outperformance can’t go on forever.\n“It would be better if this index took a breather,” said Matt Maley, chief market strategist at Miller Tabak & Co. “It would actually help the tech sector rally further into the end of the year.”\nIn an early sign that the Nasdaq 100 may be running out of steam, the index fell Monday for the first time in 11 sessions, snapping the longest winning streak since December 2020. It had finished last week at a record high.\nHowever, it’s not a given that the benchmark is headed for a double-digit decline, because it can stay at overbought levels for a long period, as in early 2020.\nWhat’s more, Citigroup Inc. strategists say the positioning on Nasdaq future contracts appeared more balanced after a chunk of bearish calls were unwound last week. “However, pockets of risk remain,” strategists led by Chris Montagu wrote in a note.\nThere’s plenty of news that can help turn sentiment against the tech sector broadly: China’s regulatory crackdown is ongoing, and there are growing signs that companies that benefited from pandemic lockdowns now are suffering as economies reopen.\nMonday’s rally in Chinese after-school tutoring stocks, spurred by a report that Beijing will issue new licenses, didn’t last long, signaling that investors expect China’s regulatory efforts have further to run.\nPayPal Holdings Inc.’s weak 2022 outlook added to concerns about slowing e-commerce sales, pushing its shares 3.8% lower in premarket trading. Among other pandemic winners, home workout equipment maker Peloton Interactive Inc. is the worst performer in the Nasdaq 100 this year with a drop of 66% and Zoom Video Communications Inc. is down 23%.\nMeanwhile, e-commerce behemoth Amazon has risen just 7% in 2021, underperforming the Nasdaq 100’s 27% surge.","news_type":1,"symbols_score_info":{".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":1718,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844771647,"gmtCreate":1636464899699,"gmtModify":1636464977879,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099194502735390","authorIdStr":"4099194502735390"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844771647","repostId":"1176992919","repostType":4,"repost":{"id":"1176992919","kind":"news","pubTimestamp":1636462320,"share":"https://www.laohu8.com/m/news/1176992919?lang=zh_CN&edition=full","pubTime":"2021-11-09 20:52","market":"us","language":"en","title":"Magic Mushroom-Based Therapy for Depression Shows Promise<blockquote>基于神奇蘑菇的抑郁症疗法显示出希望</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176992919","media":"Bloomberg","summary":"(Bloomberg) -- Compass Pathways Plc’s experimental therapy based on psilocybin, or so-called magic m","content":"<p>(Bloomberg) -- Compass Pathways Plc’s experimental therapy based on psilocybin, or so-called magic mushrooms, showed promise in a midstage clinical trial in patients whose depression didn’t improve from other treatments.</p><p><blockquote>（彭博社）——Compass Pathways Plc基于裸盖菇素（即所谓的神奇蘑菇）的实验性疗法在一项中期临床试验中显示出希望，该试验针对的是抑郁症通过其他治疗没有改善的患者。</blockquote></p><p> Nearly a quarter of the people treated with the highest dose of Compass Pathways’ drug candidate, called COMP360, saw the severity of their depression reduced after three months, as measured on a scale used by psychiatrists. COMP360 is a patented formulation of the active ingredient in psychedelic mushrooms.</p><p><blockquote>根据精神病学家使用的量表测量，接受最高剂量Compass Pathways候选药物COMP360治疗的近四分之一的人在三个月后抑郁症的严重程度有所减轻。COMP360是迷幻蘑菇中活性成分的专利配方。</blockquote></p><p> “A high dose of psilocybin works immediately, the day after, for a large number of people, and continues to work,” Compass Chief Executive Officer George Goldsmith said in an interview before the results were made public in a press release. Patients in the trial also all received psychological counseling in addition to the drug.</p><p><blockquote>Compass首席执行官乔治·戈德史密斯(George Goldsmith)在结果在新闻稿中公布之前接受采访时表示：“高剂量的裸盖菇素在第二天对很多人立即起作用，并且继续起作用。”除了药物之外，试验中的患者还接受了心理咨询。</blockquote></p><p> Goldsmith said the company believes its 233-person test, a Phase 2b study, is the largest and most rigorous ever done on psilocybin. He called the controlled, double-blind trial significant given it involved 10 countries and seven languages. Only people who had tried two or more prior medications for depression and failed to find relief were included.</p><p><blockquote>戈德史密斯表示，该公司相信其233人的2b期研究是有史以来对裸盖菇素进行的规模最大、最严格的测试。他称这项对照双盲试验意义重大，因为它涉及10个国家和7种语言。只有那些之前尝试过两种或两种以上抑郁症药物但未能缓解的人被包括在内。</blockquote></p><p> The results will be of interest to investors in the nascent psychedelics industry, and in particular the U.K.-based company’s top shareholder, Atai Life Sciences NV. Psychedelic stocks have had a rocky road so far this year.</p><p><blockquote>新兴迷幻药行业的投资者，特别是这家英国公司的最大股东Atai Life Sciences NV将对结果感兴趣。今年到目前为止，迷幻股的道路并不平坦。</blockquote></p><p> Compass shares rose as much as 42% in volatile premarket trading Tuesday. They were up 15% to $49.65 at 7:23 a.m. in New York, while Atai advanced 7.8% to $18.</p><p><blockquote>周二盘前交易中，Compass股价上涨42%。截至纽约上午7点23分，该股上涨15%，至49.65美元，Atai上涨7.8%，至18美元。</blockquote></p><p> Many startups in the space have business models built around treatment centers or other therapies that tout the promise of psilocybin or similar molecules. While mushrooms have been used for centuries, there are few clinical data on them.</p><p><blockquote>该领域的许多初创公司都围绕治疗中心或其他疗法建立了商业模式，宣扬裸盖菇素或类似分子的前景。虽然蘑菇已经被使用了几个世纪，但关于它们的临床数据很少。</blockquote></p><p> At the Wonderland conference on the psychedelics industry in Miami on Monday, some participants on a panel addressed the potential for Compass’s results to have a ripple effect.</p><p><blockquote>周一在迈阿密举行的迷幻药行业仙境会议上，一个小组的一些参与者谈到了Compass的结果可能产生连锁反应。</blockquote></p><p> “If the data is positive from Compass, there will definitely not be a funding crunch,” said Patrick Trucchio, a biotech analyst at H.C. Wainwright &amp; Co., before the release of the trial results.</p><p><blockquote>H.C.生物技术分析师Patrick Trucchio表示：“如果Compass的数据是积极的，那么肯定不会出现资金紧缩。”温赖特公司，在试验结果公布之前。</blockquote></p><p> Goldsmith declined to comment on whether its results could be extrapolated to natural psilocybin found in psychedelic mushrooms, saying those contain other compounds and don’t have the precise dosing and purity of COMP360, which involves a crystal form in capsules.</p><p><blockquote>戈德史密斯拒绝评论其结果是否可以外推到迷幻蘑菇中发现的天然裸盖菇素，称这些蘑菇含有其他化合物，并且没有COMP360的精确剂量和纯度，COMP360涉及胶囊中的一种晶体形式。</blockquote></p><p> Final Approval</p><p><blockquote>最终批准</blockquote></p><p> The company needs an even larger study before it can seek final regulatory approval. Goldsmith said that study could begin next year if the U.S. Food and Drug Administration agrees, and Compass could seek final approval by 2024 or 2025.</p><p><blockquote>该公司需要进行更大规模的研究才能寻求最终监管机构的批准。戈德史密斯说，如果美国。美国食品和药物管理局对此表示同意，Compass可能会在2024年或2025年之前寻求最终批准。</blockquote></p><p> The medicine has already received the agency’s “breakthrough therapy” designation, which is meant to speed up the drug-development process. Compass estimates that more than 100 million people worldwide have treatment-resistant depression, and as many as 30% attempt suicide.</p><p><blockquote>该药物已经获得该机构的“突破性疗法”称号，这意味着加快药物开发进程。Compass估计，全球有超过1亿人患有难治性抑郁症，多达30%的人试图自杀。</blockquote></p><p> There were five patient withdrawals from the trial at the highest dose, compared with about twice as many people on the lower doses who left the trial. Most patients reported at least one mostly mild or moderate side effect, including headache, nausea, fatigue and insomnia.</p><p><blockquote>最高剂量组有5名患者退出试验，而较低剂量组退出试验的人数约为两倍。大多数患者报告了至少一种主要为轻度或中度的副作用，包括头痛、恶心、疲劳和失眠。</blockquote></p><p> There were also 12 people in the study who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves. This shows the importance of having therapy alongside psilocybin-based treatments, Goldsmith said. The trial included “integration” sessions to help patients process their experience, as well as follow-up sessions.</p><p><blockquote>研究中还有12人表现出自杀行为或想法，或表现出伤害自己的意图。戈德史密斯说，这表明了在裸盖菇素治疗的同时进行治疗的重要性。该试验包括帮助患者处理其经历的“整合”会议，以及后续会议。</blockquote></p><p> Goldsmith said some of the troubled behavior was among the people who hadn’t actually responded to COMP360. Among three participants who exhibited suicidal behavior, two didn’t initially respond to the treatment, while none of the patients with suicidal thoughts had responded. It’s possible that it may have been an effect of their underlying condition -- or even the fact that the drug had failed to help them -- rather than the drug itself, he said.</p><p><blockquote>戈德史密斯说，一些问题行为发生在那些实际上没有对COMP360做出回应的人身上。在三名表现出自杀行为的参与者中，两名最初对治疗没有反应，而有自杀想法的患者都没有反应。他说，这可能是他们潜在疾病的影响，甚至是药物未能帮助他们的事实，而不是药物本身。</blockquote></p><p> “This is not a panacea,” he said. “People have such high expectations. And for some, this might be the last thing they think they can try.”</p><p><blockquote>“这不是灵丹妙药，”他说。“人们有如此高的期望。对一些人来说，这可能是他们认为可以尝试的最后一件事。”</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Magic Mushroom-Based Therapy for Depression Shows Promise<blockquote>基于神奇蘑菇的抑郁症疗法显示出希望</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMagic Mushroom-Based Therapy for Depression Shows Promise<blockquote>基于神奇蘑菇的抑郁症疗法显示出希望</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-11-09 20:52</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Compass Pathways Plc’s experimental therapy based on psilocybin, or so-called magic mushrooms, showed promise in a midstage clinical trial in patients whose depression didn’t improve from other treatments.</p><p><blockquote>（彭博社）——Compass Pathways Plc基于裸盖菇素（即所谓的神奇蘑菇）的实验性疗法在一项中期临床试验中显示出希望，该试验针对的是抑郁症通过其他治疗没有改善的患者。</blockquote></p><p> Nearly a quarter of the people treated with the highest dose of Compass Pathways’ drug candidate, called COMP360, saw the severity of their depression reduced after three months, as measured on a scale used by psychiatrists. COMP360 is a patented formulation of the active ingredient in psychedelic mushrooms.</p><p><blockquote>根据精神病学家使用的量表测量，接受最高剂量Compass Pathways候选药物COMP360治疗的近四分之一的人在三个月后抑郁症的严重程度有所减轻。COMP360是迷幻蘑菇中活性成分的专利配方。</blockquote></p><p> “A high dose of psilocybin works immediately, the day after, for a large number of people, and continues to work,” Compass Chief Executive Officer George Goldsmith said in an interview before the results were made public in a press release. Patients in the trial also all received psychological counseling in addition to the drug.</p><p><blockquote>Compass首席执行官乔治·戈德史密斯(George Goldsmith)在结果在新闻稿中公布之前接受采访时表示：“高剂量的裸盖菇素在第二天对很多人立即起作用，并且继续起作用。”除了药物之外，试验中的患者还接受了心理咨询。</blockquote></p><p> Goldsmith said the company believes its 233-person test, a Phase 2b study, is the largest and most rigorous ever done on psilocybin. He called the controlled, double-blind trial significant given it involved 10 countries and seven languages. Only people who had tried two or more prior medications for depression and failed to find relief were included.</p><p><blockquote>戈德史密斯表示，该公司相信其233人的2b期研究是有史以来对裸盖菇素进行的规模最大、最严格的测试。他称这项对照双盲试验意义重大，因为它涉及10个国家和7种语言。只有那些之前尝试过两种或两种以上抑郁症药物但未能缓解的人被包括在内。</blockquote></p><p> The results will be of interest to investors in the nascent psychedelics industry, and in particular the U.K.-based company’s top shareholder, Atai Life Sciences NV. Psychedelic stocks have had a rocky road so far this year.</p><p><blockquote>新兴迷幻药行业的投资者，特别是这家英国公司的最大股东Atai Life Sciences NV将对结果感兴趣。今年到目前为止，迷幻股的道路并不平坦。</blockquote></p><p> Compass shares rose as much as 42% in volatile premarket trading Tuesday. They were up 15% to $49.65 at 7:23 a.m. in New York, while Atai advanced 7.8% to $18.</p><p><blockquote>周二盘前交易中，Compass股价上涨42%。截至纽约上午7点23分，该股上涨15%，至49.65美元，Atai上涨7.8%，至18美元。</blockquote></p><p> Many startups in the space have business models built around treatment centers or other therapies that tout the promise of psilocybin or similar molecules. While mushrooms have been used for centuries, there are few clinical data on them.</p><p><blockquote>该领域的许多初创公司都围绕治疗中心或其他疗法建立了商业模式，宣扬裸盖菇素或类似分子的前景。虽然蘑菇已经被使用了几个世纪，但关于它们的临床数据很少。</blockquote></p><p> At the Wonderland conference on the psychedelics industry in Miami on Monday, some participants on a panel addressed the potential for Compass’s results to have a ripple effect.</p><p><blockquote>周一在迈阿密举行的迷幻药行业仙境会议上，一个小组的一些参与者谈到了Compass的结果可能产生连锁反应。</blockquote></p><p> “If the data is positive from Compass, there will definitely not be a funding crunch,” said Patrick Trucchio, a biotech analyst at H.C. Wainwright &amp; Co., before the release of the trial results.</p><p><blockquote>H.C.生物技术分析师Patrick Trucchio表示：“如果Compass的数据是积极的，那么肯定不会出现资金紧缩。”温赖特公司，在试验结果公布之前。</blockquote></p><p> Goldsmith declined to comment on whether its results could be extrapolated to natural psilocybin found in psychedelic mushrooms, saying those contain other compounds and don’t have the precise dosing and purity of COMP360, which involves a crystal form in capsules.</p><p><blockquote>戈德史密斯拒绝评论其结果是否可以外推到迷幻蘑菇中发现的天然裸盖菇素，称这些蘑菇含有其他化合物，并且没有COMP360的精确剂量和纯度，COMP360涉及胶囊中的一种晶体形式。</blockquote></p><p> Final Approval</p><p><blockquote>最终批准</blockquote></p><p> The company needs an even larger study before it can seek final regulatory approval. Goldsmith said that study could begin next year if the U.S. Food and Drug Administration agrees, and Compass could seek final approval by 2024 or 2025.</p><p><blockquote>该公司需要进行更大规模的研究才能寻求最终监管机构的批准。戈德史密斯说，如果美国。美国食品和药物管理局对此表示同意，Compass可能会在2024年或2025年之前寻求最终批准。</blockquote></p><p> The medicine has already received the agency’s “breakthrough therapy” designation, which is meant to speed up the drug-development process. Compass estimates that more than 100 million people worldwide have treatment-resistant depression, and as many as 30% attempt suicide.</p><p><blockquote>该药物已经获得该机构的“突破性疗法”称号，这意味着加快药物开发进程。Compass估计，全球有超过1亿人患有难治性抑郁症，多达30%的人试图自杀。</blockquote></p><p> There were five patient withdrawals from the trial at the highest dose, compared with about twice as many people on the lower doses who left the trial. Most patients reported at least one mostly mild or moderate side effect, including headache, nausea, fatigue and insomnia.</p><p><blockquote>最高剂量组有5名患者退出试验，而较低剂量组退出试验的人数约为两倍。大多数患者报告了至少一种主要为轻度或中度的副作用，包括头痛、恶心、疲劳和失眠。</blockquote></p><p> There were also 12 people in the study who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves. This shows the importance of having therapy alongside psilocybin-based treatments, Goldsmith said. The trial included “integration” sessions to help patients process their experience, as well as follow-up sessions.</p><p><blockquote>研究中还有12人表现出自杀行为或想法，或表现出伤害自己的意图。戈德史密斯说，这表明了在裸盖菇素治疗的同时进行治疗的重要性。该试验包括帮助患者处理其经历的“整合”会议，以及后续会议。</blockquote></p><p> Goldsmith said some of the troubled behavior was among the people who hadn’t actually responded to COMP360. Among three participants who exhibited suicidal behavior, two didn’t initially respond to the treatment, while none of the patients with suicidal thoughts had responded. It’s possible that it may have been an effect of their underlying condition -- or even the fact that the drug had failed to help them -- rather than the drug itself, he said.</p><p><blockquote>戈德史密斯说，一些问题行为发生在那些实际上没有对COMP360做出回应的人身上。在三名表现出自杀行为的参与者中，两名最初对治疗没有反应，而有自杀想法的患者都没有反应。他说，这可能是他们潜在疾病的影响，甚至是药物未能帮助他们的事实，而不是药物本身。</blockquote></p><p> “This is not a panacea,” he said. “People have such high expectations. And for some, this might be the last thing they think they can try.”</p><p><blockquote>“这不是灵丹妙药，”他说。“人们有如此高的期望。对一些人来说，这可能是他们认为可以尝试的最后一件事。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/magic-mushroom-based-therapy-depression-122402488.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CMPS":"COMPASS Pathways plc"},"source_url":"https://finance.yahoo.com/news/magic-mushroom-based-therapy-depression-122402488.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176992919","content_text":"(Bloomberg) -- Compass Pathways Plc’s experimental therapy based on psilocybin, or so-called magic mushrooms, showed promise in a midstage clinical trial in patients whose depression didn’t improve from other treatments.\nNearly a quarter of the people treated with the highest dose of Compass Pathways’ drug candidate, called COMP360, saw the severity of their depression reduced after three months, as measured on a scale used by psychiatrists. COMP360 is a patented formulation of the active ingredient in psychedelic mushrooms.\n“A high dose of psilocybin works immediately, the day after, for a large number of people, and continues to work,” Compass Chief Executive Officer George Goldsmith said in an interview before the results were made public in a press release. Patients in the trial also all received psychological counseling in addition to the drug.\nGoldsmith said the company believes its 233-person test, a Phase 2b study, is the largest and most rigorous ever done on psilocybin. He called the controlled, double-blind trial significant given it involved 10 countries and seven languages. Only people who had tried two or more prior medications for depression and failed to find relief were included.\nThe results will be of interest to investors in the nascent psychedelics industry, and in particular the U.K.-based company’s top shareholder, Atai Life Sciences NV. Psychedelic stocks have had a rocky road so far this year.\nCompass shares rose as much as 42% in volatile premarket trading Tuesday. They were up 15% to $49.65 at 7:23 a.m. in New York, while Atai advanced 7.8% to $18.\nMany startups in the space have business models built around treatment centers or other therapies that tout the promise of psilocybin or similar molecules. While mushrooms have been used for centuries, there are few clinical data on them.\nAt the Wonderland conference on the psychedelics industry in Miami on Monday, some participants on a panel addressed the potential for Compass’s results to have a ripple effect.\n“If the data is positive from Compass, there will definitely not be a funding crunch,” said Patrick Trucchio, a biotech analyst at H.C. Wainwright & Co., before the release of the trial results.\nGoldsmith declined to comment on whether its results could be extrapolated to natural psilocybin found in psychedelic mushrooms, saying those contain other compounds and don’t have the precise dosing and purity of COMP360, which involves a crystal form in capsules.\nFinal Approval\nThe company needs an even larger study before it can seek final regulatory approval. Goldsmith said that study could begin next year if the U.S. Food and Drug Administration agrees, and Compass could seek final approval by 2024 or 2025.\nThe medicine has already received the agency’s “breakthrough therapy” designation, which is meant to speed up the drug-development process. Compass estimates that more than 100 million people worldwide have treatment-resistant depression, and as many as 30% attempt suicide.\nThere were five patient withdrawals from the trial at the highest dose, compared with about twice as many people on the lower doses who left the trial. Most patients reported at least one mostly mild or moderate side effect, including headache, nausea, fatigue and insomnia.\nThere were also 12 people in the study who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves. This shows the importance of having therapy alongside psilocybin-based treatments, Goldsmith said. The trial included “integration” sessions to help patients process their experience, as well as follow-up sessions.\nGoldsmith said some of the troubled behavior was among the people who hadn’t actually responded to COMP360. Among three participants who exhibited suicidal behavior, two didn’t initially respond to the treatment, while none of the patients with suicidal thoughts had responded. It’s possible that it may have been an effect of their underlying condition -- or even the fact that the drug had failed to help them -- rather than the drug itself, he said.\n“This is not a panacea,” he said. “People have such high expectations. And for some, this might be the last thing they think they can try.”","news_type":1,"symbols_score_info":{"CMPS":0.9}},"isVote":1,"tweetType":1,"viewCount":2147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844771982,"gmtCreate":1636464879669,"gmtModify":1636464919769,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099194502735390","authorIdStr":"4099194502735390"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844771982","repostId":"1195351588","repostType":4,"isVote":1,"tweetType":1,"viewCount":2137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846783318,"gmtCreate":1636114117612,"gmtModify":1636117719498,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099194502735390","authorIdStr":"4099194502735390"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846783318","repostId":"1142385683","repostType":4,"repost":{"id":"1142385683","kind":"news","pubTimestamp":1636108868,"share":"https://www.laohu8.com/m/news/1142385683?lang=zh_CN&edition=full","pubTime":"2021-11-05 18:41","market":"us","language":"en","title":"Real Good Food Prices IPO At $12/Share, Below Expected Range<blockquote>Real Good Food IPO价格为12美元/股，低于预期范围</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142385683","media":"Benzinga","summary":"Real Good Food Company Inc has priced its initial public offering (IPO) of 5.3 million shares of Cla","content":"<p><div> Real Good Food Company Inc has priced its initial public offering (IPO) of 5.3 million shares of Class A common stock at $12 per share. Founded in 2016, Real Good Foods develops, markets, and ...</p><p><blockquote><div>Real Good Food Company Inc将其530万股A类普通股的首次公开募股(IPO)定价为每股12美元。Real Good Foods成立于2016年，开发、营销和...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Real Good Food Prices IPO At $12/Share, Below Expected Range<blockquote>Real Good Food IPO价格为12美元/股，低于预期范围</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReal Good Food Prices IPO At $12/Share, Below Expected Range<blockquote>Real Good Food IPO价格为12美元/股，低于预期范围</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-05 18:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Real Good Food Company Inc has priced its initial public offering (IPO) of 5.3 million shares of Class A common stock at $12 per share. Founded in 2016, Real Good Foods develops, markets, and ...</p><p><blockquote><div>Real Good Food Company Inc将其530万股A类普通股的首次公开募股(IPO)定价为每股12美元。Real Good Foods成立于2016年，开发、营销和...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RLGDF":"Real Good Food PLC"},"source_url":"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142385683","content_text":"Real Good Food Company Inc has priced its initial public offering (IPO) of 5.3 million shares of Class A common stock at $12 per share.\nFounded in 2016, Real Good Foods develops, markets, and manufactures comfort foods intended to be sold in the health and wellness segment of the frozen food category.\nThe company and a selling stockholder have also granted the underwriters a 30-day option to purchase up to an additional 0.8 million shares at IPO price.\nReal Good Food had expected to price the IPO at $14 - $16 per share.\nReal Good Foods expects gross proceeds from this offering to be approximately $64.0 million.\nThe company expects the shares to begin trading on the Nasdaq Global Market on November 5, 2021, under the ticker symbol \"RGF.\"\nThe company expects the offering to close on November 9, 2021.\nJefferies and William Blair & Company, L.L.C. are serving as lead book-running managers for the offering.","news_type":1,"symbols_score_info":{"RLGDF":0.9}},"isVote":1,"tweetType":1,"viewCount":2148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846424517,"gmtCreate":1636107451888,"gmtModify":1636107764582,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099194502735390","authorIdStr":"4099194502735390"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846424517","repostId":"2181651717","repostType":4,"isVote":1,"tweetType":1,"viewCount":1793,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846424681,"gmtCreate":1636107430144,"gmtModify":1636107756897,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4099194502735390","authorIdStr":"4099194502735390"},"themes":[],"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846424681","repostId":"2181651717","repostType":4,"isVote":1,"tweetType":1,"viewCount":2465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":844771982,"gmtCreate":1636464879669,"gmtModify":1636464919769,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099194502735390","idStr":"4099194502735390"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844771982","repostId":"1195351588","repostType":4,"repost":{"id":"1195351588","kind":"news","pubTimestamp":1636461941,"share":"https://www.laohu8.com/m/news/1195351588?lang=zh_CN&edition=full","pubTime":"2021-11-09 20:45","market":"us","language":"en","title":"Naomi Osaka-backed Sweetgreen targets up to $2.7 bln valuation in IPO<blockquote>大坂直美支持的Sweetgreen IPO估值目标高达27亿美元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1195351588","media":"Reuters","summary":"Nov 9 (Reuters) - Tennis star Naomi Osaka-backed salad chain Sweetgreen Inc said on Tuesday it was s","content":"<p>Nov 9 (Reuters) - Tennis star Naomi Osaka-backed salad chain Sweetgreen Inc said on Tuesday it was seeking a valuation of up to $2.7 billion in its initial public offering in the United States.</p><p><blockquote>路透11月9日-网球明星大坂直美支持的沙拉连锁店Sweetgreen Inc周二表示，正在美国首次公开募股中寻求高达27亿美元的估值。</blockquote></p><p> The Los Angeles, California-based company plans to sell 12.5 million shares priced between $23 and $25 each, aiming to raise up to $312.5 million at the top end of the range.</p><p><blockquote>这家总部位于加利福尼亚州洛杉矶的公司计划出售1250万股股票，每股价格在23美元至25美元之间，目标是筹集至多3.125亿美元的资金。</blockquote></p><p> Plant-based food companies have attracted investor attention over the past few years, particularly as more people gravitate to healthy and environment-friendly food.</p><p><blockquote>过去几年，植物性食品公司吸引了投资者的关注，特别是随着越来越多的人被健康和环保食品所吸引。</blockquote></p><p> Much of the demand is being led by millennials and generation Z consumers, who are more than willing to spend on sustainable products that are also healthy.</p><p><blockquote>大部分需求是由千禧一代和Z世代消费者主导的，他们非常愿意花钱购买健康的可持续产品。</blockquote></p><p> The company was valued at $1.8 billion after a funding round earlier this year, according to media reports. T.Rowe Price, Lone Pine Capital and D1 Capital Partners are among its other investors.</p><p><blockquote>据媒体报道，该公司在今年早些时候的一轮融资后估值为18亿美元。T.Rowe Price、Lone Pine Capital和D1 Capital Partners是其其他投资者。</blockquote></p><p> Sweetgreen, which was founded in 2007, expects to list on the New York Stock Exchange under the ticker symbol 'SG'.</p><p><blockquote>Sweetgreen成立于2007年，预计将在纽约证券交易所上市，股票代码为“SG”。</blockquote></p><p> Goldman Sachs, J.P. Morgan, Morgan Stanley and Allen &amp; Company are among the underwriters for the offering.</p><p><blockquote>高盛、摩根大通、摩根士丹利和艾伦公司是此次发行的承销商。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Naomi Osaka-backed Sweetgreen targets up to $2.7 bln valuation in IPO<blockquote>大坂直美支持的Sweetgreen IPO估值目标高达27亿美元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNaomi Osaka-backed Sweetgreen targets up to $2.7 bln valuation in IPO<blockquote>大坂直美支持的Sweetgreen IPO估值目标高达27亿美元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-09 20:45</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Nov 9 (Reuters) - Tennis star Naomi Osaka-backed salad chain Sweetgreen Inc said on Tuesday it was seeking a valuation of up to $2.7 billion in its initial public offering in the United States.</p><p><blockquote>路透11月9日-网球明星大坂直美支持的沙拉连锁店Sweetgreen Inc周二表示，正在美国首次公开募股中寻求高达27亿美元的估值。</blockquote></p><p> The Los Angeles, California-based company plans to sell 12.5 million shares priced between $23 and $25 each, aiming to raise up to $312.5 million at the top end of the range.</p><p><blockquote>这家总部位于加利福尼亚州洛杉矶的公司计划出售1250万股股票，每股价格在23美元至25美元之间，目标是筹集至多3.125亿美元的资金。</blockquote></p><p> Plant-based food companies have attracted investor attention over the past few years, particularly as more people gravitate to healthy and environment-friendly food.</p><p><blockquote>过去几年，植物性食品公司吸引了投资者的关注，特别是随着越来越多的人被健康和环保食品所吸引。</blockquote></p><p> Much of the demand is being led by millennials and generation Z consumers, who are more than willing to spend on sustainable products that are also healthy.</p><p><blockquote>大部分需求是由千禧一代和Z世代消费者主导的，他们非常愿意花钱购买健康的可持续产品。</blockquote></p><p> The company was valued at $1.8 billion after a funding round earlier this year, according to media reports. T.Rowe Price, Lone Pine Capital and D1 Capital Partners are among its other investors.</p><p><blockquote>据媒体报道，该公司在今年早些时候的一轮融资后估值为18亿美元。T.Rowe Price、Lone Pine Capital和D1 Capital Partners是其其他投资者。</blockquote></p><p> Sweetgreen, which was founded in 2007, expects to list on the New York Stock Exchange under the ticker symbol 'SG'.</p><p><blockquote>Sweetgreen成立于2007年，预计将在纽约证券交易所上市，股票代码为“SG”。</blockquote></p><p> Goldman Sachs, J.P. Morgan, Morgan Stanley and Allen &amp; Company are among the underwriters for the offering.</p><p><blockquote>高盛、摩根大通、摩根士丹利和艾伦公司是此次发行的承销商。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/1-naomi-osaka-backed-sweetgreen-123849434.html\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IPO":"Renaissance IPO ETF"},"source_url":"https://finance.yahoo.com/news/1-naomi-osaka-backed-sweetgreen-123849434.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195351588","content_text":"Nov 9 (Reuters) - Tennis star Naomi Osaka-backed salad chain Sweetgreen Inc said on Tuesday it was seeking a valuation of up to $2.7 billion in its initial public offering in the United States.\nThe Los Angeles, California-based company plans to sell 12.5 million shares priced between $23 and $25 each, aiming to raise up to $312.5 million at the top end of the range.\nPlant-based food companies have attracted investor attention over the past few years, particularly as more people gravitate to healthy and environment-friendly food.\nMuch of the demand is being led by millennials and generation Z consumers, who are more than willing to spend on sustainable products that are also healthy.\nThe company was valued at $1.8 billion after a funding round earlier this year, according to media reports. T.Rowe Price, Lone Pine Capital and D1 Capital Partners are among its other investors.\nSweetgreen, which was founded in 2007, expects to list on the New York Stock Exchange under the ticker symbol 'SG'.\nGoldman Sachs, J.P. Morgan, Morgan Stanley and Allen & Company are among the underwriters for the offering.","news_type":1,"symbols_score_info":{"IPO":0.9}},"isVote":1,"tweetType":1,"viewCount":2137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846424517,"gmtCreate":1636107451888,"gmtModify":1636107764582,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099194502735390","idStr":"4099194502735390"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846424517","repostId":"2181651717","repostType":4,"isVote":1,"tweetType":1,"viewCount":1793,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844778274,"gmtCreate":1636464967934,"gmtModify":1636466228111,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099194502735390","idStr":"4099194502735390"},"themes":[],"htmlText":"Yup","listText":"Yup","text":"Yup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844778274","repostId":"1118064093","repostType":4,"repost":{"id":"1118064093","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636457742,"share":"https://www.laohu8.com/m/news/1118064093?lang=zh_CN&edition=full","pubTime":"2021-11-09 19:35","market":"us","language":"en","title":"General Electric shares jumped more than 8% in premarket trading.<blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1118064093","media":"Tiger Newspress","summary":"General Electric shares jumped more than 8% in premarket trading.\nGE today announced its plan to for","content":"<p>General&nbsp;Electric&nbsp;shares&nbsp;jumped&nbsp;more&nbsp;than&nbsp;8%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/1049bfebf2182acd1079e4e631f5655b\" tg-width=\"882\" tg-height=\"578\" referrerpolicy=\"no-referrer\"></p><p><blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote></p><p> GE&nbsp;today announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy, by:</p><p><blockquote>GE今天宣布计划通过以下方式组建三家行业领先的全球上市公司，专注于航空、医疗保健和能源等增长领域：</blockquote></p><p> <ol>  <li>Pursuing a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023, in which GE expects to retain a stake of 19.9 percent; and</li>  <li>Combining GE Renewable Energy, GE Power, and GE Digital into one business, positioned to lead the energy transition, and then pursuing a tax-free spin-off of this business in early 2024.</li>  <li>Following these transactions, GE will be an aviation-focused company shaping the future of flight.</li> </ol></p><p><blockquote><ol><li>寻求免税分拆GE Healthcare，于2023年初在precision health中心创建一家纯粹的公司，GE预计将保留19.9%的股份；和</li><li>将GE可再生能源、GE电力和GE数字合并为一项业务，定位于引领能源转型，然后在2024年初寻求该业务的免税分拆。</li><li>完成这些交易后，通用电气将成为一家专注于航空的公司，塑造航空业的未来。</li></ol></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>General Electric shares jumped more than 8% in premarket trading.<blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGeneral Electric shares jumped more than 8% in premarket trading.<blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-09 19:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>General&nbsp;Electric&nbsp;shares&nbsp;jumped&nbsp;more&nbsp;than&nbsp;8%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/1049bfebf2182acd1079e4e631f5655b\" tg-width=\"882\" tg-height=\"578\" referrerpolicy=\"no-referrer\"></p><p><blockquote>通用电气股价在盘前交易中上涨超过8%。</blockquote></p><p> GE&nbsp;today announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy, by:</p><p><blockquote>GE今天宣布计划通过以下方式组建三家行业领先的全球上市公司，专注于航空、医疗保健和能源等增长领域：</blockquote></p><p> <ol>  <li>Pursuing a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023, in which GE expects to retain a stake of 19.9 percent; and</li>  <li>Combining GE Renewable Energy, GE Power, and GE Digital into one business, positioned to lead the energy transition, and then pursuing a tax-free spin-off of this business in early 2024.</li>  <li>Following these transactions, GE will be an aviation-focused company shaping the future of flight.</li> </ol></p><p><blockquote><ol><li>寻求免税分拆GE Healthcare，于2023年初在precision health中心创建一家纯粹的公司，GE预计将保留19.9%的股份；和</li><li>将GE可再生能源、GE电力和GE数字合并为一项业务，定位于引领能源转型，然后在2024年初寻求该业务的免税分拆。</li><li>完成这些交易后，通用电气将成为一家专注于航空的公司，塑造航空业的未来。</li></ol></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GE":"GE航空航天"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118064093","content_text":"General Electric shares jumped more than 8% in premarket trading.\nGE today announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy, by:\n\nPursuing a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023, in which GE expects to retain a stake of 19.9 percent; and\nCombining GE Renewable Energy, GE Power, and GE Digital into one business, positioned to lead the energy transition, and then pursuing a tax-free spin-off of this business in early 2024.\nFollowing these transactions, GE will be an aviation-focused company shaping the future of flight.","news_type":1,"symbols_score_info":{"GE":0.9}},"isVote":1,"tweetType":1,"viewCount":3197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846424681,"gmtCreate":1636107430144,"gmtModify":1636107756897,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099194502735390","idStr":"4099194502735390"},"themes":[],"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846424681","repostId":"2181651717","repostType":4,"isVote":1,"tweetType":1,"viewCount":2465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844771647,"gmtCreate":1636464899699,"gmtModify":1636464977879,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099194502735390","idStr":"4099194502735390"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844771647","repostId":"1176992919","repostType":4,"repost":{"id":"1176992919","kind":"news","pubTimestamp":1636462320,"share":"https://www.laohu8.com/m/news/1176992919?lang=zh_CN&edition=full","pubTime":"2021-11-09 20:52","market":"us","language":"en","title":"Magic Mushroom-Based Therapy for Depression Shows Promise<blockquote>基于神奇蘑菇的抑郁症疗法显示出希望</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176992919","media":"Bloomberg","summary":"(Bloomberg) -- Compass Pathways Plc’s experimental therapy based on psilocybin, or so-called magic m","content":"<p>(Bloomberg) -- Compass Pathways Plc’s experimental therapy based on psilocybin, or so-called magic mushrooms, showed promise in a midstage clinical trial in patients whose depression didn’t improve from other treatments.</p><p><blockquote>（彭博社）——Compass Pathways Plc基于裸盖菇素（即所谓的神奇蘑菇）的实验性疗法在一项中期临床试验中显示出希望，该试验针对的是抑郁症通过其他治疗没有改善的患者。</blockquote></p><p> Nearly a quarter of the people treated with the highest dose of Compass Pathways’ drug candidate, called COMP360, saw the severity of their depression reduced after three months, as measured on a scale used by psychiatrists. COMP360 is a patented formulation of the active ingredient in psychedelic mushrooms.</p><p><blockquote>根据精神病学家使用的量表测量，接受最高剂量Compass Pathways候选药物COMP360治疗的近四分之一的人在三个月后抑郁症的严重程度有所减轻。COMP360是迷幻蘑菇中活性成分的专利配方。</blockquote></p><p> “A high dose of psilocybin works immediately, the day after, for a large number of people, and continues to work,” Compass Chief Executive Officer George Goldsmith said in an interview before the results were made public in a press release. Patients in the trial also all received psychological counseling in addition to the drug.</p><p><blockquote>Compass首席执行官乔治·戈德史密斯(George Goldsmith)在结果在新闻稿中公布之前接受采访时表示：“高剂量的裸盖菇素在第二天对很多人立即起作用，并且继续起作用。”除了药物之外，试验中的患者还接受了心理咨询。</blockquote></p><p> Goldsmith said the company believes its 233-person test, a Phase 2b study, is the largest and most rigorous ever done on psilocybin. He called the controlled, double-blind trial significant given it involved 10 countries and seven languages. Only people who had tried two or more prior medications for depression and failed to find relief were included.</p><p><blockquote>戈德史密斯表示，该公司相信其233人的2b期研究是有史以来对裸盖菇素进行的规模最大、最严格的测试。他称这项对照双盲试验意义重大，因为它涉及10个国家和7种语言。只有那些之前尝试过两种或两种以上抑郁症药物但未能缓解的人被包括在内。</blockquote></p><p> The results will be of interest to investors in the nascent psychedelics industry, and in particular the U.K.-based company’s top shareholder, Atai Life Sciences NV. Psychedelic stocks have had a rocky road so far this year.</p><p><blockquote>新兴迷幻药行业的投资者，特别是这家英国公司的最大股东Atai Life Sciences NV将对结果感兴趣。今年到目前为止，迷幻股的道路并不平坦。</blockquote></p><p> Compass shares rose as much as 42% in volatile premarket trading Tuesday. They were up 15% to $49.65 at 7:23 a.m. in New York, while Atai advanced 7.8% to $18.</p><p><blockquote>周二盘前交易中，Compass股价上涨42%。截至纽约上午7点23分，该股上涨15%，至49.65美元，Atai上涨7.8%，至18美元。</blockquote></p><p> Many startups in the space have business models built around treatment centers or other therapies that tout the promise of psilocybin or similar molecules. While mushrooms have been used for centuries, there are few clinical data on them.</p><p><blockquote>该领域的许多初创公司都围绕治疗中心或其他疗法建立了商业模式，宣扬裸盖菇素或类似分子的前景。虽然蘑菇已经被使用了几个世纪，但关于它们的临床数据很少。</blockquote></p><p> At the Wonderland conference on the psychedelics industry in Miami on Monday, some participants on a panel addressed the potential for Compass’s results to have a ripple effect.</p><p><blockquote>周一在迈阿密举行的迷幻药行业仙境会议上，一个小组的一些参与者谈到了Compass的结果可能产生连锁反应。</blockquote></p><p> “If the data is positive from Compass, there will definitely not be a funding crunch,” said Patrick Trucchio, a biotech analyst at H.C. Wainwright &amp; Co., before the release of the trial results.</p><p><blockquote>H.C.生物技术分析师Patrick Trucchio表示：“如果Compass的数据是积极的，那么肯定不会出现资金紧缩。”温赖特公司，在试验结果公布之前。</blockquote></p><p> Goldsmith declined to comment on whether its results could be extrapolated to natural psilocybin found in psychedelic mushrooms, saying those contain other compounds and don’t have the precise dosing and purity of COMP360, which involves a crystal form in capsules.</p><p><blockquote>戈德史密斯拒绝评论其结果是否可以外推到迷幻蘑菇中发现的天然裸盖菇素，称这些蘑菇含有其他化合物，并且没有COMP360的精确剂量和纯度，COMP360涉及胶囊中的一种晶体形式。</blockquote></p><p> Final Approval</p><p><blockquote>最终批准</blockquote></p><p> The company needs an even larger study before it can seek final regulatory approval. Goldsmith said that study could begin next year if the U.S. Food and Drug Administration agrees, and Compass could seek final approval by 2024 or 2025.</p><p><blockquote>该公司需要进行更大规模的研究才能寻求最终监管机构的批准。戈德史密斯说，如果美国。美国食品和药物管理局对此表示同意，Compass可能会在2024年或2025年之前寻求最终批准。</blockquote></p><p> The medicine has already received the agency’s “breakthrough therapy” designation, which is meant to speed up the drug-development process. Compass estimates that more than 100 million people worldwide have treatment-resistant depression, and as many as 30% attempt suicide.</p><p><blockquote>该药物已经获得该机构的“突破性疗法”称号，这意味着加快药物开发进程。Compass估计，全球有超过1亿人患有难治性抑郁症，多达30%的人试图自杀。</blockquote></p><p> There were five patient withdrawals from the trial at the highest dose, compared with about twice as many people on the lower doses who left the trial. Most patients reported at least one mostly mild or moderate side effect, including headache, nausea, fatigue and insomnia.</p><p><blockquote>最高剂量组有5名患者退出试验，而较低剂量组退出试验的人数约为两倍。大多数患者报告了至少一种主要为轻度或中度的副作用，包括头痛、恶心、疲劳和失眠。</blockquote></p><p> There were also 12 people in the study who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves. This shows the importance of having therapy alongside psilocybin-based treatments, Goldsmith said. The trial included “integration” sessions to help patients process their experience, as well as follow-up sessions.</p><p><blockquote>研究中还有12人表现出自杀行为或想法，或表现出伤害自己的意图。戈德史密斯说，这表明了在裸盖菇素治疗的同时进行治疗的重要性。该试验包括帮助患者处理其经历的“整合”会议，以及后续会议。</blockquote></p><p> Goldsmith said some of the troubled behavior was among the people who hadn’t actually responded to COMP360. Among three participants who exhibited suicidal behavior, two didn’t initially respond to the treatment, while none of the patients with suicidal thoughts had responded. It’s possible that it may have been an effect of their underlying condition -- or even the fact that the drug had failed to help them -- rather than the drug itself, he said.</p><p><blockquote>戈德史密斯说，一些问题行为发生在那些实际上没有对COMP360做出回应的人身上。在三名表现出自杀行为的参与者中，两名最初对治疗没有反应，而有自杀想法的患者都没有反应。他说，这可能是他们潜在疾病的影响，甚至是药物未能帮助他们的事实，而不是药物本身。</blockquote></p><p> “This is not a panacea,” he said. “People have such high expectations. And for some, this might be the last thing they think they can try.”</p><p><blockquote>“这不是灵丹妙药，”他说。“人们有如此高的期望。对一些人来说，这可能是他们认为可以尝试的最后一件事。”</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Magic Mushroom-Based Therapy for Depression Shows Promise<blockquote>基于神奇蘑菇的抑郁症疗法显示出希望</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMagic Mushroom-Based Therapy for Depression Shows Promise<blockquote>基于神奇蘑菇的抑郁症疗法显示出希望</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-11-09 20:52</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Compass Pathways Plc’s experimental therapy based on psilocybin, or so-called magic mushrooms, showed promise in a midstage clinical trial in patients whose depression didn’t improve from other treatments.</p><p><blockquote>（彭博社）——Compass Pathways Plc基于裸盖菇素（即所谓的神奇蘑菇）的实验性疗法在一项中期临床试验中显示出希望，该试验针对的是抑郁症通过其他治疗没有改善的患者。</blockquote></p><p> Nearly a quarter of the people treated with the highest dose of Compass Pathways’ drug candidate, called COMP360, saw the severity of their depression reduced after three months, as measured on a scale used by psychiatrists. COMP360 is a patented formulation of the active ingredient in psychedelic mushrooms.</p><p><blockquote>根据精神病学家使用的量表测量，接受最高剂量Compass Pathways候选药物COMP360治疗的近四分之一的人在三个月后抑郁症的严重程度有所减轻。COMP360是迷幻蘑菇中活性成分的专利配方。</blockquote></p><p> “A high dose of psilocybin works immediately, the day after, for a large number of people, and continues to work,” Compass Chief Executive Officer George Goldsmith said in an interview before the results were made public in a press release. Patients in the trial also all received psychological counseling in addition to the drug.</p><p><blockquote>Compass首席执行官乔治·戈德史密斯(George Goldsmith)在结果在新闻稿中公布之前接受采访时表示：“高剂量的裸盖菇素在第二天对很多人立即起作用，并且继续起作用。”除了药物之外，试验中的患者还接受了心理咨询。</blockquote></p><p> Goldsmith said the company believes its 233-person test, a Phase 2b study, is the largest and most rigorous ever done on psilocybin. He called the controlled, double-blind trial significant given it involved 10 countries and seven languages. Only people who had tried two or more prior medications for depression and failed to find relief were included.</p><p><blockquote>戈德史密斯表示，该公司相信其233人的2b期研究是有史以来对裸盖菇素进行的规模最大、最严格的测试。他称这项对照双盲试验意义重大，因为它涉及10个国家和7种语言。只有那些之前尝试过两种或两种以上抑郁症药物但未能缓解的人被包括在内。</blockquote></p><p> The results will be of interest to investors in the nascent psychedelics industry, and in particular the U.K.-based company’s top shareholder, Atai Life Sciences NV. Psychedelic stocks have had a rocky road so far this year.</p><p><blockquote>新兴迷幻药行业的投资者，特别是这家英国公司的最大股东Atai Life Sciences NV将对结果感兴趣。今年到目前为止，迷幻股的道路并不平坦。</blockquote></p><p> Compass shares rose as much as 42% in volatile premarket trading Tuesday. They were up 15% to $49.65 at 7:23 a.m. in New York, while Atai advanced 7.8% to $18.</p><p><blockquote>周二盘前交易中，Compass股价上涨42%。截至纽约上午7点23分，该股上涨15%，至49.65美元，Atai上涨7.8%，至18美元。</blockquote></p><p> Many startups in the space have business models built around treatment centers or other therapies that tout the promise of psilocybin or similar molecules. While mushrooms have been used for centuries, there are few clinical data on them.</p><p><blockquote>该领域的许多初创公司都围绕治疗中心或其他疗法建立了商业模式，宣扬裸盖菇素或类似分子的前景。虽然蘑菇已经被使用了几个世纪，但关于它们的临床数据很少。</blockquote></p><p> At the Wonderland conference on the psychedelics industry in Miami on Monday, some participants on a panel addressed the potential for Compass’s results to have a ripple effect.</p><p><blockquote>周一在迈阿密举行的迷幻药行业仙境会议上，一个小组的一些参与者谈到了Compass的结果可能产生连锁反应。</blockquote></p><p> “If the data is positive from Compass, there will definitely not be a funding crunch,” said Patrick Trucchio, a biotech analyst at H.C. Wainwright &amp; Co., before the release of the trial results.</p><p><blockquote>H.C.生物技术分析师Patrick Trucchio表示：“如果Compass的数据是积极的，那么肯定不会出现资金紧缩。”温赖特公司，在试验结果公布之前。</blockquote></p><p> Goldsmith declined to comment on whether its results could be extrapolated to natural psilocybin found in psychedelic mushrooms, saying those contain other compounds and don’t have the precise dosing and purity of COMP360, which involves a crystal form in capsules.</p><p><blockquote>戈德史密斯拒绝评论其结果是否可以外推到迷幻蘑菇中发现的天然裸盖菇素，称这些蘑菇含有其他化合物，并且没有COMP360的精确剂量和纯度，COMP360涉及胶囊中的一种晶体形式。</blockquote></p><p> Final Approval</p><p><blockquote>最终批准</blockquote></p><p> The company needs an even larger study before it can seek final regulatory approval. Goldsmith said that study could begin next year if the U.S. Food and Drug Administration agrees, and Compass could seek final approval by 2024 or 2025.</p><p><blockquote>该公司需要进行更大规模的研究才能寻求最终监管机构的批准。戈德史密斯说，如果美国。美国食品和药物管理局对此表示同意，Compass可能会在2024年或2025年之前寻求最终批准。</blockquote></p><p> The medicine has already received the agency’s “breakthrough therapy” designation, which is meant to speed up the drug-development process. Compass estimates that more than 100 million people worldwide have treatment-resistant depression, and as many as 30% attempt suicide.</p><p><blockquote>该药物已经获得该机构的“突破性疗法”称号，这意味着加快药物开发进程。Compass估计，全球有超过1亿人患有难治性抑郁症，多达30%的人试图自杀。</blockquote></p><p> There were five patient withdrawals from the trial at the highest dose, compared with about twice as many people on the lower doses who left the trial. Most patients reported at least one mostly mild or moderate side effect, including headache, nausea, fatigue and insomnia.</p><p><blockquote>最高剂量组有5名患者退出试验，而较低剂量组退出试验的人数约为两倍。大多数患者报告了至少一种主要为轻度或中度的副作用，包括头痛、恶心、疲劳和失眠。</blockquote></p><p> There were also 12 people in the study who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves. This shows the importance of having therapy alongside psilocybin-based treatments, Goldsmith said. The trial included “integration” sessions to help patients process their experience, as well as follow-up sessions.</p><p><blockquote>研究中还有12人表现出自杀行为或想法，或表现出伤害自己的意图。戈德史密斯说，这表明了在裸盖菇素治疗的同时进行治疗的重要性。该试验包括帮助患者处理其经历的“整合”会议，以及后续会议。</blockquote></p><p> Goldsmith said some of the troubled behavior was among the people who hadn’t actually responded to COMP360. Among three participants who exhibited suicidal behavior, two didn’t initially respond to the treatment, while none of the patients with suicidal thoughts had responded. It’s possible that it may have been an effect of their underlying condition -- or even the fact that the drug had failed to help them -- rather than the drug itself, he said.</p><p><blockquote>戈德史密斯说，一些问题行为发生在那些实际上没有对COMP360做出回应的人身上。在三名表现出自杀行为的参与者中，两名最初对治疗没有反应，而有自杀想法的患者都没有反应。他说，这可能是他们潜在疾病的影响，甚至是药物未能帮助他们的事实，而不是药物本身。</blockquote></p><p> “This is not a panacea,” he said. “People have such high expectations. And for some, this might be the last thing they think they can try.”</p><p><blockquote>“这不是灵丹妙药，”他说。“人们有如此高的期望。对一些人来说，这可能是他们认为可以尝试的最后一件事。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/magic-mushroom-based-therapy-depression-122402488.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CMPS":"COMPASS Pathways plc"},"source_url":"https://finance.yahoo.com/news/magic-mushroom-based-therapy-depression-122402488.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176992919","content_text":"(Bloomberg) -- Compass Pathways Plc’s experimental therapy based on psilocybin, or so-called magic mushrooms, showed promise in a midstage clinical trial in patients whose depression didn’t improve from other treatments.\nNearly a quarter of the people treated with the highest dose of Compass Pathways’ drug candidate, called COMP360, saw the severity of their depression reduced after three months, as measured on a scale used by psychiatrists. COMP360 is a patented formulation of the active ingredient in psychedelic mushrooms.\n“A high dose of psilocybin works immediately, the day after, for a large number of people, and continues to work,” Compass Chief Executive Officer George Goldsmith said in an interview before the results were made public in a press release. Patients in the trial also all received psychological counseling in addition to the drug.\nGoldsmith said the company believes its 233-person test, a Phase 2b study, is the largest and most rigorous ever done on psilocybin. He called the controlled, double-blind trial significant given it involved 10 countries and seven languages. Only people who had tried two or more prior medications for depression and failed to find relief were included.\nThe results will be of interest to investors in the nascent psychedelics industry, and in particular the U.K.-based company’s top shareholder, Atai Life Sciences NV. Psychedelic stocks have had a rocky road so far this year.\nCompass shares rose as much as 42% in volatile premarket trading Tuesday. They were up 15% to $49.65 at 7:23 a.m. in New York, while Atai advanced 7.8% to $18.\nMany startups in the space have business models built around treatment centers or other therapies that tout the promise of psilocybin or similar molecules. While mushrooms have been used for centuries, there are few clinical data on them.\nAt the Wonderland conference on the psychedelics industry in Miami on Monday, some participants on a panel addressed the potential for Compass’s results to have a ripple effect.\n“If the data is positive from Compass, there will definitely not be a funding crunch,” said Patrick Trucchio, a biotech analyst at H.C. Wainwright & Co., before the release of the trial results.\nGoldsmith declined to comment on whether its results could be extrapolated to natural psilocybin found in psychedelic mushrooms, saying those contain other compounds and don’t have the precise dosing and purity of COMP360, which involves a crystal form in capsules.\nFinal Approval\nThe company needs an even larger study before it can seek final regulatory approval. Goldsmith said that study could begin next year if the U.S. Food and Drug Administration agrees, and Compass could seek final approval by 2024 or 2025.\nThe medicine has already received the agency’s “breakthrough therapy” designation, which is meant to speed up the drug-development process. Compass estimates that more than 100 million people worldwide have treatment-resistant depression, and as many as 30% attempt suicide.\nThere were five patient withdrawals from the trial at the highest dose, compared with about twice as many people on the lower doses who left the trial. Most patients reported at least one mostly mild or moderate side effect, including headache, nausea, fatigue and insomnia.\nThere were also 12 people in the study who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves. This shows the importance of having therapy alongside psilocybin-based treatments, Goldsmith said. The trial included “integration” sessions to help patients process their experience, as well as follow-up sessions.\nGoldsmith said some of the troubled behavior was among the people who hadn’t actually responded to COMP360. Among three participants who exhibited suicidal behavior, two didn’t initially respond to the treatment, while none of the patients with suicidal thoughts had responded. It’s possible that it may have been an effect of their underlying condition -- or even the fact that the drug had failed to help them -- rather than the drug itself, he said.\n“This is not a panacea,” he said. “People have such high expectations. And for some, this might be the last thing they think they can try.”","news_type":1,"symbols_score_info":{"CMPS":0.9}},"isVote":1,"tweetType":1,"viewCount":2147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846783318,"gmtCreate":1636114117612,"gmtModify":1636117719498,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099194502735390","idStr":"4099194502735390"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846783318","repostId":"1142385683","repostType":4,"repost":{"id":"1142385683","kind":"news","pubTimestamp":1636108868,"share":"https://www.laohu8.com/m/news/1142385683?lang=zh_CN&edition=full","pubTime":"2021-11-05 18:41","market":"us","language":"en","title":"Real Good Food Prices IPO At $12/Share, Below Expected Range<blockquote>Real Good Food IPO价格为12美元/股，低于预期范围</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1142385683","media":"Benzinga","summary":"Real Good Food Company Inc has priced its initial public offering (IPO) of 5.3 million shares of Cla","content":"<p><div> Real Good Food Company Inc has priced its initial public offering (IPO) of 5.3 million shares of Class A common stock at $12 per share. Founded in 2016, Real Good Foods develops, markets, and ...</p><p><blockquote><div>Real Good Food Company Inc将其530万股A类普通股的首次公开募股(IPO)定价为每股12美元。Real Good Foods成立于2016年，开发、营销和...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Real Good Food Prices IPO At $12/Share, Below Expected Range<blockquote>Real Good Food IPO价格为12美元/股，低于预期范围</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReal Good Food Prices IPO At $12/Share, Below Expected Range<blockquote>Real Good Food IPO价格为12美元/股，低于预期范围</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-05 18:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Real Good Food Company Inc has priced its initial public offering (IPO) of 5.3 million shares of Class A common stock at $12 per share. Founded in 2016, Real Good Foods develops, markets, and ...</p><p><blockquote><div>Real Good Food Company Inc将其530万股A类普通股的首次公开募股(IPO)定价为每股12美元。Real Good Foods成立于2016年，开发、营销和...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RLGDF":"Real Good Food PLC"},"source_url":"https://www.benzinga.com/news/21/11/23917459/real-good-food-prices-ipo-at-12share-below-expected-range","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142385683","content_text":"Real Good Food Company Inc has priced its initial public offering (IPO) of 5.3 million shares of Class A common stock at $12 per share.\nFounded in 2016, Real Good Foods develops, markets, and manufactures comfort foods intended to be sold in the health and wellness segment of the frozen food category.\nThe company and a selling stockholder have also granted the underwriters a 30-day option to purchase up to an additional 0.8 million shares at IPO price.\nReal Good Food had expected to price the IPO at $14 - $16 per share.\nReal Good Foods expects gross proceeds from this offering to be approximately $64.0 million.\nThe company expects the shares to begin trading on the Nasdaq Global Market on November 5, 2021, under the ticker symbol \"RGF.\"\nThe company expects the offering to close on November 9, 2021.\nJefferies and William Blair & Company, L.L.C. are serving as lead book-running managers for the offering.","news_type":1,"symbols_score_info":{"RLGDF":0.9}},"isVote":1,"tweetType":1,"viewCount":2148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844771772,"gmtCreate":1636464911695,"gmtModify":1636465037593,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099194502735390","idStr":"4099194502735390"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844771772","repostId":"1170173504","repostType":4,"isVote":1,"tweetType":1,"viewCount":1718,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844778160,"gmtCreate":1636464944962,"gmtModify":1636465147770,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099194502735390","idStr":"4099194502735390"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844778160","repostId":"2182270499","repostType":4,"isVote":1,"tweetType":1,"viewCount":3442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844778951,"gmtCreate":1636464922462,"gmtModify":1636465092493,"author":{"id":"4099194502735390","authorId":"4099194502735390","name":"shineyee","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4099194502735390","idStr":"4099194502735390"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844778951","repostId":"2182023117","repostType":4,"isVote":1,"tweetType":1,"viewCount":1534,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}